{
  "docId": "019dd923-622c-750b-8b9a-101b5bfde4b8",
  "docSlug": "a70fecd99534",
  "documentTitle": "Berkeley Lights (BLI)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-09-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 157,
  "pageCount": 158,
  "prevPage": 156,
  "nextPage": 158,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "Includes direct quotes from former BLI scientists as evidence of competitive displacement.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "screenshot",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-101b5bfde4b8/157",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8#slide-157",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Former employees indicated that 10X Genomics (ticker: TXG) is also a significant competitive threat, stating that both 10X Genomics and Abcellera deliver the same single cell information as BLI but at 5% of the cost.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-2042-70a9-a1b0-e80ecbff964d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "image",
      "text": "Chromium X instrument",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "adcfcea0-0349-42a3-af87-7400bdc2a464",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.9,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "other",
      "text": "Source: Scorpion Capital consultation calls with experts; 10xgenomics.com; genomeweb.com",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c37ac61-1958-4412-8f0c-b738f08056bb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "Former employees indicated that 10X Genomics (ticker: TXG) is also a significant competitive threat, stating that both 10X Genomics and Abcellera deliver the same single cell information as BLI but at 5% of the cost. We note 10X cut its prices again last month. Ex-employees state it's not only cheaper but offers better capabilities and far higher throughput.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c69ea56-db1c-451e-979f-8bb0369967ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.75
      },
      "kind": "quote",
      "text": "10X Genomics offers better capabilities and radically higher throughput for 5% of the price of BLI's machine... Our throughput was a few thousand cells, while on platforms like 10X Genomics, you can have hundreds of thousands.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "096f31ea-9784-409f-a179-4f66c0ec65ef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "quote",
      "text": "Abcellera and 10X Genomics platforms deliver the same single cell information for a fraction of the cost of BLI... There are ways to obtain the same information.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15eeb927-e44f-409e-89bf-79549f56bf4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"The Abcellera system has the same possibility because it's based on a very similar concept to the Berkeley Lights system; it doesn't use optoelectrical positioning to move the cells around, but has a 3D based, gravity-based system to isolate single cells, but then you can also put them in chambers when you put them together with other cells so that you can do a functional assay. So, that part could be done with the Abcellera system. Some other aspects of the activation of a cell that is producing antibodies can also be monitored to a specific type of assay that is compatible with the 10X Genomics platform based on encapsulating it in droplets, not like single cells but a B cell and potential target cells together in the same droplet and then monitoring the behavior of the B cell and then staining. There are ways to obtain the same information.\" — Former BLI scientist",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-2042-70a9-a1b0-ec9bcc5a86cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Part 2) Former BLI employees/executives: Competition from cheaper, better alternatives has already rendered BLI irrelevant",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a1b32fa-6521-4321-8165-378905dc900e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.28,
        "y": 0.3
      },
      "kind": "title",
      "text": "10x Genomics Introduces New Chromium X Series for Single Cell Analysis\n10x Genomics Sees Bump in Chromium Instrument Sales After Price Drop",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c71c061f-8a61-4785-974c-53b2853b8588",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "2576dcde-b137-4b6a-9d97-74a2a30b6d82",
      "evidence": "Slide explicitly frames 10X Genomics and Abcellera as competitive threats rendering BLI irrelevant.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}